September 2017


In this Issue


The Forces Driving Care




Guest Chief Medical Editors’ Page

Superficial Femoral Artery: The Forces Driving Care

By Gary M. Ansel, MD, FACC; and Koen Deloose, MD


A US Perspective: SFA CTO Crossing: Is Perfection Possible?

A formal credentialing criteria for femoropopliteal chronic total occlusions.

By John A. Phillips, MD

A European Perspective: Valued Care and the Potential for CTO Credentialing

The current treatment landscape for complex superficial femoral artery lesions and recommendations for improvement.

By Luis Mariano Palena, MD; Efrem Gomez Jabalera, MD; and Marco Manzi, MD

Peripheral Vascular Care: A Clinical and Administrative Perspective

Michael R. Jaff, DO, answers questions posed by Gary M. Ansel, MD, FACC, and Koen Deloose, MD, on the challenges of his new role as hospital president and how new regulatory and reimbursement models might affect vascular care delivery.

With Michael R. Jaff, DO; Gary M. Ansel, MD, FACC; and Koen Deloose, MD

Perspectives: Does Care Drive Reimbursement or Vice Versa?

By Tony S. Das, MD, FACP, FACC; and Yann Gouëffic, MD, PhD

Vessel Preparation and Plaque Modification of Infrainguinal Lesions

Defining the terms, discussing the data, and reviewing perspectives on current practices.

By Ehrin J. Armstrong, MD; and Marianne Brodmann, MD

The Challenges of Calcium in Peripheral Artery Disease

Dr. Rocha-Singh discusses the available methods for calcium assessment and scoring, how calcium affects procedural success, and the goals of the VIVA calcium scoring unification initiative.

With Krishna Rocha-Singh, MD

What’s Next in Drug-Eluting SFA Technology?

Juan Granada, MD, discusses potential next-generation advancements in drugs, delivery methods, and study.

With Juan F. Granada, MD, FACC

Ask the Experts: Perfect Pairing: Which Stent Properties Are the Best Match for Drug-Coated Balloons?

Experts weigh in on properties of available stent technology and which combinations could be used to improve femoropopliteal disease outcomes.

With Stavros Spiliopoulos, MD, PhD, EBIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Mark W. Burket, MD; and Thomas Zeller, MD


Sponsored by PQ Bypass

What Goes Around Comes Around: Fully Endovascular Femoropopliteal Bypass

With long-term durability of SFA interventions still a challenge, a new approach should be considered.

By Grzegorz Halena, MD, PhD; and Jane Bailly, PhD


Sponsored by Medtronic

Vessel Preparation: Understanding the Concept and Its Need

By Venkatesh G. Ramaiah, MD, FACS


Sponsored by Cardiovascular Systems, Inc.

Long-Term Data From Liberty 360° Show Positive Impact for Patients Receiving Endovascular Therapy

A roundtable discussion of the real-world LIBERTY 360° 12-month data and the study’s significance in treating patients with peripheral artery disease and critical limb ischemia.

With Ehrin J. Armstrong, MD; Jihad A. Mustapha, MD; George A. Pliagas, MD; and Jason A. Yoho, MD


Sponsored by Veryan Medical Ltd.

The Impact of Swirling Flow in Treating Atherosclerosis in the Superficial Femoral Artery

Producing better results in primary stenting and the ideal complement to drug-coated balloons.

By Peter A. Gaines, MD


The VTE Landscape and SIR’s ACTiVE Meeting

Dr. Kush Desai discusses the genesis of the ACTiVE educational forum, VTE intervention, and IVC filter retrieval.

With Kush Desai, MD


An Interview With Janet T. Powell, MD, PhD, FRCPath

Prof. Powell discusses her work as a trial investigator, including what the latest EVAR data show and areas that warrant further study.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.